Thrivent Financial for Lutherans’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $99M | Sell |
787,299
-91,516
| -10% | -$11.5M | 0.22% | 106 |
|
2025
Q1 | $97.2M | Buy |
878,815
+141,043
| +19% | +$15.6M | 0.21% | 108 |
|
2024
Q4 | $101M | Buy |
737,772
+711,970
| +2,759% | +$97.2M | 0.2% | 124 |
|
2024
Q3 | $2.97M | Sell |
25,802
-20,775
| -45% | -$2.39M | 0.01% | 1189 |
|
2024
Q2 | $6.41M | Buy |
46,577
+21,641
| +87% | +$2.98M | 0.01% | 803 |
|
2024
Q1 | $3.44M | Buy |
24,936
+391
| +2% | +$53.9K | 0.01% | 1059 |
|
2023
Q4 | $3.23M | Buy |
24,545
+94
| +0.4% | +$12.4K | 0.01% | 1052 |
|
2023
Q3 | $2.75M | Sell |
24,451
-734
| -3% | -$82.6K | 0.01% | 1079 |
|
2023
Q2 | $2.38M | Sell |
25,185
-305
| -1% | -$28.8K | 0.01% | 1238 |
|
2023
Q1 | $2.58M | Sell |
25,490
-4,782
| -16% | -$484K | 0.01% | 1127 |
|
2022
Q4 | $3.62M | Buy |
30,272
+4,959
| +20% | +$592K | 0.01% | 917 |
|
2022
Q3 | $2.69M | Buy |
25,313
+238
| +0.9% | +$25.3K | 0.01% | 1052 |
|
2022
Q2 | $2.44M | Buy |
25,075
+285
| +1% | +$27.8K | 0.01% | 1119 |
|
2022
Q1 | $2.32M | Sell |
24,790
-224
| -0.9% | -$21K | ﹤0.01% | 1230 |
|
2021
Q4 | $2.13M | Buy |
25,014
+275
| +1% | +$23.4K | ﹤0.01% | 1356 |
|
2021
Q3 | $2.37M | Sell |
24,739
-360
| -1% | -$34.5K | ﹤0.01% | 1243 |
|
2021
Q2 | $2.44M | Buy |
25,099
+124
| +0.5% | +$12.1K | 0.01% | 1286 |
|
2021
Q1 | $2.43M | Buy |
+24,975
| New | +$2.43M | 0.01% | 1298 |
|
2020
Q4 | – | Sell |
-35,625
| Closed | -$3.43M | – | 2493 |
|
2020
Q3 | $3.43M | Sell |
35,625
-192,400
| -84% | -$18.5M | 0.01% | 914 |
|
2020
Q2 | $27.8M | Buy |
228,025
+1,075
| +0.5% | +$131K | 0.08% | 280 |
|
2020
Q1 | $19.6M | Sell |
226,950
-49
| -0% | -$4.24K | 0.07% | 318 |
|
2019
Q4 | $24.4M | Buy |
226,999
+20,464
| +10% | +$2.2M | 0.07% | 324 |
|
2019
Q3 | $18.6M | Buy |
206,535
+6,176
| +3% | +$557K | 0.06% | 342 |
|
2019
Q2 | $16.9M | Buy |
200,359
+14,752
| +8% | +$1.25M | 0.05% | 374 |
|
2019
Q1 | $16.4M | Sell |
185,607
-506,244
| -73% | -$44.6M | 0.05% | 361 |
|
2018
Q4 | $49.4M | Buy |
691,851
+336,101
| +94% | +$24M | 0.18% | 148 |
|
2018
Q3 | $43.7M | Buy |
355,750
+101,517
| +40% | +$12.5M | 0.14% | 181 |
|
2018
Q2 | $25M | Buy |
254,233
+2,834
| +1% | +$278K | 0.08% | 256 |
|
2018
Q1 | $20.8M | Sell |
251,399
-364
| -0.1% | -$30.2K | 0.07% | 277 |
|
2017
Q4 | $19.5M | Sell |
251,763
-830
| -0.3% | -$64.4K | 0.07% | 284 |
|
2017
Q3 | $15.5M | Hold |
252,593
| – | – | 0.05% | 313 |
|
2017
Q2 | $11.6M | Hold |
252,593
| – | – | 0.05% | 362 |
|
2017
Q1 | $10.9M | Hold |
252,593
| – | – | 0.05% | 363 |
|
2016
Q4 | $9.78M | Sell |
252,593
-760
| -0.3% | -$29.4K | 0.04% | 394 |
|
2016
Q3 | $12.8M | Buy |
253,353
+4,600
| +2% | +$233K | 0.06% | 316 |
|
2016
Q2 | $11.3M | Hold |
248,753
| – | – | 0.05% | 338 |
|
2016
Q1 | $9.84M | Buy |
248,753
+2,940
| +1% | +$116K | 0.05% | 364 |
|
2015
Q4 | $13.9M | Sell |
245,813
-35,530
| -13% | -$2.01M | 0.07% | 270 |
|
2015
Q3 | $11.2M | Buy |
281,343
+52,520
| +23% | +$2.09M | 0.06% | 310 |
|
2015
Q2 | $10.9M | Buy |
228,823
+4,400
| +2% | +$210K | 0.06% | 310 |
|
2015
Q1 | $8.91M | Sell |
224,423
-420,990
| -65% | -$16.7M | 0.05% | 362 |
|
2014
Q4 | $14.4M | Sell |
645,413
-10,650
| -2% | -$238K | 0.08% | 260 |
|
2014
Q3 | $10.3M | Sell |
656,063
-15,500
| -2% | -$243K | 0.06% | 307 |
|
2014
Q2 | $9.96M | Sell |
671,563
-427
| -0.1% | -$6.34K | 0.06% | 329 |
|
2014
Q1 | $10.8M | Buy |
671,990
+223,050
| +50% | +$3.59M | 0.07% | 287 |
|
2013
Q4 | $4.19M | Buy |
448,940
+109,050
| +32% | +$1.02M | 0.03% | 470 |
|
2013
Q3 | $3.85M | Sell |
339,890
-7,010
| -2% | -$79.4K | 0.02% | 478 |
|
2013
Q2 | $4.64K | Buy |
+346,900
| New | +$4.64K | 0.03% | 439 |
|